Andra AP-fonden

Position in RPRX — Royalty Pharma plc

CIK 1535452 GOTEBORG, V7

Position in RPRX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$8,514,675

+$2,933,192 QoQ

Shares Held

177,500

-10.7% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Andra AP-fonden holds $89,889,169 across 7 Biotechnology names. RPRX ranks #5 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	86,697	$28,685,436
2	INCY	Incyte Corp	259,048	$24,381,597
3	INSM	INSMED Inc	77,970	$12,749,654
4	VRTX	Vertex Pharmaceuticals Inc / Ma	23,903	$10,673,645
5	RPRX	Royalty Pharma plc This page	177,500	$8,514,675
6	REGN	Regeneron Pharmaceuticals, Inc.	4,232	$3,269,812
7	RVMD	Revolution Medicines, Inc.	16,600	$1,614,350

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,514,675	177,500	-10.7%	Shares	Sole	2026-05-08
2023-12-31	$5,581,483	198,700	+25.6%	Shares	Sole	2024-02-15
2023-09-30	$4,293,548	158,200	+3.6%	Shares	Sole	2023-11-09
2023-06-30	$4,693,998	152,700	+38.1%	Shares	Sole	2023-08-09
2023-03-31	$3,984,918	110,600	-27.1%	Shares	Sole	2023-05-12
2022-12-31	$5,999,136	151,800	-10.8%	Shares	Sole	2023-02-13
2022-09-30	$6,838,636	170,200	+22.2%	Shares	Sole	2022-11-14
2022-06-30	$5,856,172	139,300	-2.1%	Shares	Sole	2022-08-15
2021-12-31	$5,670,655	142,300	-10.3%	Shares	Sole	2022-02-15
2021-09-30	$5,731,804	158,600	+21.9%	Shares	Sole	2021-11-12
2021-06-30	$5,332,799	130,100	+29.7%	Shares	Sole	2021-08-16
2021-03-31	$4,375,086	100,300	-14.1%	Shares	Sole	2021-05-17
2020-12-31	$5,845,840	116,800	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.